Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiformeSusan M Chang, Kathleen R Lamborn, Mary Malec, et al.Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survivalRalph P Ermoian, Constance S Furniss, Kathleen R Lamborn, et al.Proceedings of the National Academy of Sciences of the United States of America|April 14, 2005
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiformeYu Liang, Maximilian Diehn, Nathan Watson, et al.Neuro-Oncology|May 12, 2004
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiformeDavid A Larson, Jeffrey M Suplica, Susan M Chang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapyLijie Zhai, Mahua Dey, Kristen L Lauing, et al.British Journal of Cancer|December 5, 2022
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignanciesOana C Danciu, Matthias Holdhoff, Richard A Peterson, et al.Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.Pageof 3